Testing effectiveness (Phase 2)Study completedNCT00744991What this trial is testingParticipants With Relapsed Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Eli Lilly and Company 25
Testing effectiveness (Phase 2)Ended earlyNCT03422679What this trial is testingStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesWho this might be right forBreast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more Cellestia Biotech AG 79
Testing effectiveness (Phase 2)Study completedNCT00059995What this trial is testingMDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04870853What this trial is testingCardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell TherapyWho this might be right forRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06014073What this trial is testingTRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHLWho this might be right forNon Hodgkin's Lymphoma Chinese PLA General Hospital 30
Post-approval studies (Phase 4)Study completedNCT01804166What this trial is testingA Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)Who this might be right forHepatosplenic T-Cell Lymphoma Janssen Scientific Affairs, LLC 1
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Not applicableStudy completedNCT00020072What this trial is testingAnalysis of Genes Present in Cutaneous T-cell Lymphoma CellsWho this might be right forLymphoma National Cancer Institute (NCI)
Not applicableStudy completedNCT02520895What this trial is testingImmunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forLYMPHOMA Hospices Civils de Lyon 98
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Early research (Phase 1)Ended earlyNCT00101205What this trial is testingOxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaWho this might be right forAngioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more National Cancer Institute (NCI) 40
Early research (Phase 1)WithdrawnNCT02238522What this trial is testingPhase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AMLWho this might be right forLymphoproliferative MalignanciesAcute Myeloid Leukemia Zenith Epigenetics
Not applicableUnknownNCT06509945What this trial is testingAllo-PBSCT as the First-line Treatment for Patients With the High-risk PTCLWho this might be right forPeripheral T Cell Lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574528What this trial is testingA Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell LymphomaWho this might be right forNKTCL Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT04601831What this trial is testing'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHLWho this might be right forNon-Hodgkin Lymphoma University of Texas Southwestern Medical Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT07380984What this trial is testingPD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCLWho this might be right forNatural Killer/T-cell Lymphoma Ruijin Hospital 47
Early research (Phase 1)Study completedNCT00002909What this trial is testingPhenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01035463What this trial is testingLenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin LymphomaWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeRecurrent Anaplastic Large Cell LymphomaRecurrent Mantle Cell Lymphoma+3 more University of Nebraska 74
Testing effectiveness (Phase 2)Ended earlyNCT02341209What this trial is testingDoxycycline for the Treatment of Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome Rochester General Hospital 1
Testing effectiveness (Phase 2)Looking for participantsNCT06839456What this trial is testingPhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCTWho this might be right forLeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more Children's Hospital of Philadelphia 100